EFFECT OF MURINE ASCITES ON THE ABILITY OF HYBRIDOMA CELLS TO PRODUCE ANTIBODY AND PROLIFERATE INVITRO

被引:1
作者
LUMANGLAS, AL [1 ]
WANG, BS [1 ]
机构
[1] AMER CYANAMID CO,DIV AGR RES,IMMUNOENDOCRINOL LAB,POB 400,PRINCETON,NJ 08543
来源
HYBRIDOMA | 1993年 / 12卷 / 01期
关键词
D O I
10.1089/hyb.1993.12.127
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Murine ascites has been shown to contain a variety of growth promoting activities. In this study, we examined the effects of ascites fluid on the efficiency of hybridoma production and cell growth. SP2/0 mouse myeloma cells were injected into peritoneal cavities of mice and ascitic fluid was collected. Lymphocytes from mice immunized with porcine growth hormone (pGH) were fused with myeloma cells in a standard hybridization procedure. These cells were then dispensed in 96-well plates in medium containing either 2.5% ascites or 20% fetal calf serum (FCS) and cultured for few days. Supernatants from these cultures were collected and analyzed for anti-pGH antibodies. It was demonstrated that ascites-supplemented medium increased the efficiency in generating specific antibody-secreting hybridomas by 4-fold over FCS-supplemented medium. Furthermore, hybridoma cells were cultured in microtiter plate and found to proliferate in response to ascites in a dose dependent manner. This effect was abolished by prior digestion of ascites with trypsin, indicating its protein nature. B-lymphocyte related cytokines seemed less likely involved because antibodies to IL-4 and IL-6 failed to alter the stimulatory effect of ascites. Ascites was fractionated by FPLC using Superose 12 column and the active moiety was found to be a small m.w. peptide (< 1,000 dalton). Therefore, murine ascites is capable of substituting for conventional FCS in culture medium in the area of hybridoma technology.
引用
收藏
页码:127 / 133
页数:7
相关论文
共 15 条
[1]  
Aarden L, 1985, LYMPHOKINES, V10, P175
[2]   IMMUNOSTIMULATORY SUBSTANCE IN THE ASCITES-FLUID OF PATIENTS WITH CANCER METASTATIC TO THE PERITONEUM [J].
BADGER, AM ;
COOPERBAND, SR .
CELLULAR IMMUNOLOGY, 1979, 45 (01) :15-25
[3]   IMMUNOSTIMULATORY AND IMMUNOSUPPRESSIVE FACTORS IN HUMAN CANCER ASCITES FLUIDS - EFFECT ON PRIMARY PLAQUE-FORMING RESPONSE INVITRO [J].
BADGER, AM ;
MERLUZZI, VJ ;
COOPERBAND, SR .
CELLULAR IMMUNOLOGY, 1976, 27 (01) :126-130
[4]   INVIVO PRODUCTION OF A MACROPHAGE GROWTH-FACTOR [J].
CIFONE, M ;
MOCARELLI, P ;
DEFENDI, V .
EXPERIMENTAL CELL RESEARCH, 1975, 96 (01) :96-102
[5]   PRODUCTION OF MONOCLONAL-ANTIBODIES - STRATEGY AND TACTICS [J].
DESTGROTH, SF ;
SCHEIDEGGER, D .
JOURNAL OF IMMUNOLOGICAL METHODS, 1980, 35 (1-2) :1-21
[6]   CONTINUOUS CULTURES OF FUSED CELLS SECRETING ANTIBODY OF PREDEFINED SPECIFICITY [J].
KOHLER, G ;
MILSTEIN, C .
NATURE, 1975, 256 (5517) :495-497
[7]   A MACROPHAGE-DERIVED FACTOR REQUIRED BY PLASMACYTOMAS FOR SURVIVAL AND PROLIFERATION INVITRO [J].
NORDAN, RP ;
POTTER, M .
SCIENCE, 1986, 233 (4763) :566-569
[8]   THEORY AND METHODS FOR IMMUNIZATION IN CULTURE AND MONOCLONAL ANTIBODY-PRODUCTION [J].
READING, CL .
JOURNAL OF IMMUNOLOGICAL METHODS, 1982, 53 (03) :261-291
[9]   BETTER CELL LINE FOR MAKING HYBRIDOMAS SECRETING SPECIFIC ANTIBODIES [J].
SHULMAN, M ;
WILDE, CD ;
KOHLER, G .
NATURE, 1978, 276 (5685) :269-270
[10]   REGULATION OF IGG1 AND IGE PRODUCTION BY INTERLEUKIN-4 [J].
SNAPPER, CM ;
FINKELMAN, FD ;
PAUL, WE .
IMMUNOLOGICAL REVIEWS, 1988, 102 :51-75